In hepatocellular carcinoma cell lines, c-Met enhanced FAK activation in a FAK kinase-dependent manner and coinduced the activation of the AKT/ERK/cyclin D1 signaling pathway, thereby upregulating cyclin D1 expression and inducing tumor cell proliferation [27]. Here, MET is linked to neoplasm.